Vanguard Group’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,279,335
| Closed | -$175M | – | 4199 |
|
|
2018
Q2 | $175M | Buy |
1,279,335
+329,708
| +35% | +$29.9M | 0.01% | 1445 |
|
|
2018
Q1 | $74.8M | Buy |
949,627
+289,528
| +44% | +$21.4M | ﹤0.01% | 1871 |
|
|
2017
Q4 | $45M | Buy |
660,099
+9,953
| +2% | +$516K | ﹤0.01% | 2111 |
|
|
2017
Q3 | $26.1M | Buy |
650,146
+18,807
| +3% | +$726K | ﹤0.01% | 2363 |
|
|
2017
Q2 | $25.1M | Buy |
631,339
+47,843
| +8% | +$1.75M | ﹤0.01% | 2360 |
|
|
2017
Q1 | $18.8M | Buy |
583,496
+28,619
| +5% | +$714K | ﹤0.01% | 2468 |
|
|
2016
Q4 | $9.82M | Buy |
554,877
+14,163
| +3% | +$305K | ﹤0.01% | 2757 |
|
|
2016
Q3 | $12.6M | Buy |
540,714
+17,776
| +3% | +$404K | ﹤0.01% | 2575 |
|
|
2016
Q2 | $9.76M | Buy |
522,938
+18,956
| +4% | +$343K | ﹤0.01% | 2661 |
|
|
2016
Q1 | $9.16M | Buy |
503,982
+6,099
| +1% | +$98.3K | ﹤0.01% | 2659 |
|
|
2015
Q4 | $10.5M | Sell |
497,883
-3,802
| -0.8% | -$73.3K | ﹤0.01% | 2608 |
|
|
2015
Q3 | $9.26M | Buy |
501,685
+15,354
| +3% | +$383K | ﹤0.01% | 2643 |
|
|
2015
Q2 | $16.5M | Sell |
486,331
-101,080
| -17% | -$4.07M | ﹤0.01% | 2441 |
|
|
2015
Q1 | $28.3M | Sell |
587,411
-40,822
| -6% | -$1.85M | ﹤0.01% | 2179 |
|
|
2014
Q4 | $14M | Buy |
628,233
+52,654
| +9% | +$1.22M | ﹤0.01% | 2402 |
|
|
2014
Q3 | $10.9M | Buy |
575,579
+244,797
| +74% | +$5.84M | ﹤0.01% | 2450 |
|
|
2014
Q2 | $8.92M | Buy |
330,782
+143,992
| +77% | +$3.65M | ﹤0.01% | 2555 |
|
|
2014
Q1 | $6.05M | Buy |
186,790
+120,850
| +183% | +$3.93M | ﹤0.01% | 2738 |
|
|
2013
Q4 | $1.57M | Buy |
+65,940
| New | +$1.84M | ﹤0.01% | 3291 |
|
Vanguard Group's FMI Position: Q3 2018 in Review
Vanguard Group sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 1,279,335 shares — an estimated $175M sold.
Vanguard Group first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $175M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Vanguard Group reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Vanguard Group sold 1,279,335 Foundation Medicine, Inc. shares in Q3 2018, an estimated $175M.
- Vanguard Group first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Vanguard Group's Foundation Medicine, Inc. position peaked at $175M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Vanguard Group's 13F filing for Q3 2018, filed 14 Nov 2018.